Hua Ren Pharmaceutical Industry: Some western and Chinese patent medicines in the selected "3+N" alliance in Beijing-Tianjin-Hebei region will be purchased in a linked manner.

Hua Ren Pharmaceutical Industry Announcement, the company and its wholly-owned subsidiary Guangxi Yuyuan Pharmaceutical Co., Ltd., Hua Ren Pharmaceutical Co., Ltd. recently actively participated in the bidding for the continuation of the volume-linked procurement of some western medicines and traditional Chinese medicines in the "3+N" alliance of Beijing-Tianjin-Hebei. According to the selected results recently announced by the Tianjin Pharmaceutical Procurement Center, the company and its wholly-owned subsidiary's products - Mixed Sugar Electrolyte Injection, Stevastatin Hydrochloride Sodium Injection, and Hydroxyethyl Starch 130/0.4 Sodium Chloride Injection - were selected for this round of volume-linked procurement.